You are on Trendlyne United States. Click here to go to India website or make United States as your default

Utah Medical Products, Inc. XNAS: UTMD

Utah Medical Products, Inc. Live Share Price Today, Share Analysis and Chart

56.81 -0.60 (-1.05%)

New 52W Low today

41,241 XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

Board Meeting
The next board meeting for Utah Medical Products, Inc. is on 26 Mar 2025 for the purpose of Utah Medical Products Inc Annual Report for 2024 See details

Utah Medical Products, Inc. Key Metrics

Default
All financials are in USD Million and price data in USD
VIEW MORE
Medium Financial Strength
38.9 / 100
Mid Valuation
45.5 / 100
Technically Bearish
32.5 / 100
Slowing Down Stock These stocks score good in Quality and also have medium range financials. However, a bad technical scoring and bearish aspects decrease the investor's interest over time. View Similar Embed DVM

Utah Medical Products, Inc. Live Price Chart

Switch to TradingView
Fetching data ...

Utah Medical Products, Inc. Stock Analysis

Utah Medical Products, Inc. stock analysis with key metrics, changes, and trends.

Utah Medical Products, Inc. MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$40.9 M18.56%negative

Annual Revenue fell 18.56%, in the last year to $40.9 M. Its sector's average revenue growth for the last fiscal year was 8.73%.

Annual Net Profit$13.87 M16.6%negative

Annual Net Profit fell 16.6% in the last year to $13.87 M. Its sector's average net profit growth for the last fiscal year was 3.53%.

Price to Earning Ratio13.66-positive

Price to Earning Ratio is 13.66, lower than its sector PE ratio of 31.17.

Stock Price$56.81-17.1%negative

Stock Price fell 17.1% and underperformed its sector by 23.53% in the past year.

Quarterly Revenue$9.16 M25.75%negative

Quarterly Revenue fell 25.75% YoY to $9.16 M. Its sector's average revenue growth YoY for the quarter was 8.57%.

Quarterly Net profit$2.9 M32.29%negative

Quarterly Net profit fell 32.29% YoY to $2.9 M. Its sector's average net profit growth YoY for the quarter was 27.52%.

Debt to Equity Ratio--positive

Debt to Equity Ratio is zero as the company is debt-free.

Return on Equity(ROE)11.29 %11.29%neutral

Return on Equity(ROE) for the last financial year was 11.29%, in the normal range of 10% to 20%.

Mutual Fund Holding49.88 %1.73%positive

Mutual Fund Holding increased by 1.73% in the last quarter to 49.88.

Promoter Share Holding1.69 %0%neutral

Promoter Share Holding stayed the same in the most recent quarter at 1.69%.

Institutional Holding68.87 %-5.42%negative

Institutional Holding decreased by 5.42% in the last quarter to 68.87.

VIEW LESS


Loading data..

Utah Medical Products, Inc. - Company Profile

What does Utah Medical Products, Inc. do?

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.

Utah Medical Products, Inc. Management structure

All Gross Remunerations are in USD
Mr. Kevin L. Cornwell
Chairman of the Board, President, Chief Executive Officer and Secretary
510.57 K
2023
Gross Remuneration
Year
Mr. Brian Koopman
Principal Financial Officer
165.32 K
2023
Gross Remuneration
Year

Utah Medical Products, Inc. Board of directors

All Gross Remunerations are in USD
Mr. Paul O. Richins
Independent Director
-
2024
Gross Remuneration
Year
Ms. Carrie Leigh
Director
-
2024
Gross Remuneration
Year

Utah Medical Products, Inc. FAQ

How is Utah Medical Products, Inc. today?
Utah Medical Products, Inc. today is trading in the red, and is down by -1.05% at 56.81.
Utah Medical Products, Inc. is currently trading down -1.05% on an intraday basis. In the past week the stock fell -0.86%. stock has been down -6.90% in the past quarter and fell -17.10% in the past year. You can view this in the overview section.